{"url":"https://lda.senate.gov/api/v1/filings/3fa4669c-3ae4-4e74-a78e-3eac0e8d5f74/","filing_uuid":"3fa4669c-3ae4-4e74-a78e-3eac0e8d5f74","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2024,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/3fa4669c-3ae4-4e74-a78e-3eac0e8d5f74/print/","filing_document_content_type":"text/html","income":null,"expenses":"73763.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Natasha SIlva","dt_posted":"2024-04-22T17:30:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"One M Street, SE","registrant_address_2":"Suite 510","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":69674,"url":"https://lda.senate.gov/api/v1/registrants/69674/","house_registrant_id":35789,"name":"NATIONAL MULTIPLE SCLEROSIS SOCIETY","description":null,"address_1":"1100 NEW YORK AVENUE, NW, #440 E","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRYANT ROBINSON","contact_telephone":"+1 978-500-8654","dt_updated":"2026-07-09T12:22:42.016422-04:00"},"client":{"id":164353,"url":"https://lda.senate.gov/api/v1/clients/164353/","client_id":12,"name":"NATIONAL MULTIPLE SCLEROSIS SOCIETY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25308,"prefix":null,"prefix_display":null,"first_name":"BARI","nickname":null,"middle_name":null,"last_name":"TALENTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106090,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"BOSCHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144348,"prefix":"ms","prefix_display":"MS.","first_name":"NATASHA","nickname":null,"middle_name":"AMARAL","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":141339,"prefix":null,"prefix_display":null,"first_name":"STEFFANY","nickname":null,"middle_name":null,"last_name":"STERN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153369,"prefix":"mr","prefix_display":"MR.","first_name":"BRYANT","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106090,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"BOSCHI","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":25308,"prefix":null,"prefix_display":null,"first_name":"BARI","nickname":null,"middle_name":null,"last_name":"TALENTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144348,"prefix":"ms","prefix_display":"MS.","first_name":"NATASHA","nickname":null,"middle_name":"AMARAL","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":141339,"prefix":null,"prefix_display":null,"first_name":"STEFFANY","nickname":null,"middle_name":null,"last_name":"STERN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153369,"prefix":"mr","prefix_display":"MR.","first_name":"BRYANT","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage (awaiting bill number) S.2254, Medicare PBM Accountability Act, support passage","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25308,"prefix":null,"prefix_display":null,"first_name":"BARI","nickname":null,"middle_name":null,"last_name":"TALENTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106090,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"BOSCHI","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":144348,"prefix":"ms","prefix_display":"MS.","first_name":"NATASHA","nickname":null,"middle_name":"AMARAL","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141339,"prefix":null,"prefix_display":null,"first_name":"STEFFANY","nickname":null,"middle_name":null,"last_name":"STERN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153369,"prefix":"mr","prefix_display":"MR.","first_name":"BRYANT","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":17,"name":"Office of Administration"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144348,"prefix":"ms","prefix_display":"MS.","first_name":"NATASHA","nickname":null,"middle_name":"AMARAL","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106090,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"BOSCHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153369,"prefix":"mr","prefix_display":"MR.","first_name":"BRYANT","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TRA","general_issue_code_display":"Transportation","description":"H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106090,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"BOSCHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":25308,"prefix":null,"prefix_display":null,"first_name":"BARI","nickname":null,"middle_name":null,"last_name":"TALENTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144348,"prefix":"ms","prefix_display":"MS.","first_name":"NATASHA","nickname":null,"middle_name":"AMARAL","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":141339,"prefix":null,"prefix_display":null,"first_name":"STEFFANY","nickname":null,"middle_name":null,"last_name":"STERN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153369,"prefix":"mr","prefix_display":"MR.","first_name":"BRYANT","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}